Most students make a full recovery but some may experience lingering symptoms of the virus even after the 10 day infectious period of symptomatic infection.
U.Va. Health’s Dr. Steven L. Zeichner and Virginia Tech’s Dr. Xiang-Jin Meng are working together to develop a potential broad spectrum coronavirus vaccine.
Researchers note that even after just a single dose, these vaccines can be anywhere from 50 to 75 percent effective in preventing COVID-19 infection.
This time last spring, COVID-19 first hit the University and caused its normal operations to shut down. Since then, U.Va. Health has taken several actions in a continuous and evolving response to the pandemic.
Physicians are often faced with tough circumstances and emphasize the role good connection and quality relationships play throughout their careers, from residency to present day.
A smart health home-monitoring system that aims to reduce cancer pain by detecting it before it arises and helps healthcare workers effectively intervene.
Dianna Damenova and Connie Zhang establish Women in Cybersecurity chapter to provide opportunities for female students to thrive within STEM fields.
Beyond just demotivation, students have experienced significant changes to overall mental health and wellness due to added stress and the disruption of normalcy.
U.Va. health care professionals spoke Tuesday in a virtual town hall to answer the public’s questions about the COVID-19 vaccines.
The study will use the data collected to predict how well the vaccine can prevent asymptomatic infection and the transmission of the virus to others.
The unexpected success of the market can be attributed to a small group of ‘stay-at-home’ stocks such as Zoom and Amazon, which have become a significant part of the S&P 500.
Over half of Americans considered internet access “essential” during the pandemic.
The team project focused on powering devices in dark areas on the moon that receive no sunlight by using lasers to transmit energy to rovers.
A select number of mutations are advantageous to the virus and increase the virus’s fitness, allowing it to spread more quickly amongst the population they infect.
A new device developed by two heart device manufacturers — called the interatrial shunt — is currently being tested in clinical trials at several sites nationwide, including at U.Va. Health. If the results of the trial prove promising, these devices could help ease symptoms in heart failure patients and increase their quality of life.
U.Va. Health is participating in clinical trials to test an antibody cocktail which is showing to providing short-term immunity against symptomatic COVID-19 infections.
Because of the public’s continued false perception, non-smokers with lung cancer face increasing stigma.
With a limited supply of vaccine doses, health officials must prioritize recipients to ensure the most at-risk and essential workers are receiving vaccinations.
Cyber-physical systems are real-world machines and systems, and attacks against them could range from changing readings and data to taking control of entire vehicles.
A report by the Weldon Cooper Center at the University shows that with integrated planning and cooperative policy, decarbonization of the Virginia economy by 2050 is both achievable and affordable.
